Introduction

LY3509754 is a small-molecule inhibitor of interleukin-17A (IL-17A). Its synthesis requires a key intermediate containing a 4,4-difluorocyclohexyl group, a chiral amino substituent, and an α-bromoketone moiety. In a 2025 process development study, 110 kg of this α-bromoketone intermediate was ultimately produced, and the overall yield of the optimized route increased from 19.1% for the preclinical supply route to 46.5%.[1]

The core of this synthesis is the use of a β-keto ester as an intermediate with tunable reactivity that can be converted, after hydrolysis, into a decarboxylatable β-keto acid. The chiral carboxylic acid is activated and then reacted with a magnesium monoethyl malonate complex to form the β-keto ester. The newly introduced central carbon is subsequently brominated and ultimately retained as the bromomethyl carbon of the α-bromoketone, whereas the ester carbonyl carbon serves as a temporary carbon and is removed as carbon dioxide after ester hydrolysis generates the β-keto acid.[1]

The early patent route and the subsequent scalable route retained this fundamental chemical logic, but the ester group and the method used to generate the β-keto acid were changed. The early route employed a tert-butyl ester followed by treatment with trifluoroacetic acid (TFA), whereas the later scalable route used an ethyl ester and employed the immobilized lipase Lipozyme TL IM to catalyze ester hydrolysis.[1,2]

1. α-Bromoketone and the β-Keto Ester Precursor

1.1 The bromine atom in an α-bromoketone is located at the carbon α to the ketone carbonyl

α-Bromoketones are a class of compounds in which a bromine atom is attached to the carbon α to a ketone carbonyl. The key intermediate in the LY3509754 route additionally contains a 4,4-difluorocyclohexyl group, a benzyloxycarbonyl-protected amino group, and a previously established stereocenter with the S configuration.

The bromomethyl group is strongly electrophilic and can participate in the subsequent construction of a nitrogen-containing heterocycle. Early patents related to LY3509754 had already disclosed this α-bromoketone and its preparation, whereas the subsequent process study established a scalable new route centered on this intermediate.[1,2]

The target α-bromoketone itself does not contain a carboxylate ester, but the scalable route deliberately introduces a carboxylate ester unit into its precursor, thereby forming a β-keto ester. This temporary structural element serves to modulate reactivity.

1.2 An additional carbonyl group changes the reactivity of the α-carbon

A β-keto ester has a typical 1,3-dicarbonyl structure, with one carbon located between a ketone carbonyl and an ester carbonyl.

The two carbonyl groups jointly influence the central methylene group, making its hydrogens easier to remove than those of an ordinary aliphatic methylene. Upon deprotonation to form an enolate, the negative charge can be delocalized by resonance over the two carbonyl groups. The corresponding enol form is also relatively accessible, making this position more susceptible to electrophilic α-functionalization.[3]

The function of the carboxylate ester at each stage is summarized below:

This “add first, remove later” structural operation follows the same general design logic as classical acetoacetic ester and malonic ester syntheses: a carbonyl-containing structural element is temporarily introduced to modulate the reactivity of a neighboring carbon, functionalization is completed, and the no-longer-needed carbon is subsequently removed by decarboxylation.[3]

In the 2025 route, the chiral carboxylic acid obtained in the preceding step was first activated with N,N′-carbonyldiimidazole (CDI) to form an acyl imidazole and was then reacted with a magnesium monoethyl malonate complex to form the β-keto ester.[1] This chain-extension step simultaneously introduces the central carbon that will subsequently be brominated and an ester carbonyl carbon that can later be removed. The central carbon is ultimately retained as the bromomethyl carbon of the α-bromoketone, whereas the ester carbonyl carbon is removed by decarboxylation after hydrolysis generates the β-keto acid.

2. α-Bromination of the β-Keto Ester

2.1 The 1,3-dicarbonyl system makes the bromination site more clearly defined

The central methylene group of the β-keto ester lies between two carbonyl groups. This electronic environment facilitates formation of an enol-type reactive species, allowing electrophilic bromine to be introduced selectively at this defined position.

The 2025 scalable process used N-bromosuccinimide (NBS) as the bromine source together with 2,6-dimethylpyridine. The reaction was conducted in ethanol at 10–20 °C for 1 h, affording the α-bromo β-keto ester in 88.3% isolated yield and 95.5% purity.[1]

At this stage, the C–Br bond required in the final α-bromoketone has already been formed, but the molecule still contains the carboxylate ester that was introduced earlier to modulate reactivity.

2.2 The temporary stereocenter generated during bromination does not remain in the final intermediate

Before bromination, the central carbon of the β-keto ester is a methylene carbon. After Br is introduced, this carbon is bonded to four different substituents, creating a new temporary stereocenter. Because the molecule already contains an S-configured stereocenter, the different configurations at this position correspond to diastereomers.

In the original study, a wavy bond was used at this C–Br position, and no single absolute configuration was assigned.

This representation is consistent with the subsequent structural transformation. After decarboxylation, the original brominated methine carbon becomes a bromomethyl carbon and is no longer a stereocenter. In other words, the stereochemical information temporarily generated during bromination disappears as the carbon skeleton changes.

What must be retained is the S-configured stereocenter established earlier at the other end of the molecule, rather than the temporary configuration at the bromination site.

3. Enzymatic Ester Hydrolysis and β-Keto Acid Decarboxylation

3.1 Lipozyme TL IM directly catalyzes ester-bond hydrolysis

Instead of treating the ethyl ester directly with a strong acid, the scalable route employed Lipozyme TL IM for enzymatic hydrolysis. Lipozyme TL IM is a commercial immobilized preparation of Thermomyces lanuginosus lipase (TLL), and lipases can catalyze both the hydrolysis of carboxylic ester bonds and the reverse reaction.[4]

The original study used 20 wt% Lipozyme TL IM, 20 volumes of methyl tert-butyl ether (MTBE), and approximately 2 wt% water at 35–45 °C for 18 h. The target α-bromoketone was ultimately obtained in 85.9% isolated yield, with 99.3% purity and 100% enantiomeric excess (ee).[1]

This experimental result comprises two consecutive but chemically distinct processes. Lipozyme TL IM catalyzes hydrolysis of the α-bromo β-keto ethyl ester to generate the corresponding β-keto acid, after which the β-keto acid undergoes concomitant decarboxylation. In other words, the enzyme catalyzes ester hydrolysis, whereas decarboxylation is the subsequent transformation of the β-keto acid formed after hydrolysis.[1]

3.2 Ester hydrolysis forms the β-keto acid

After hydrolysis of the ester bond, the original carboxylate ester is converted into a carboxylic acid while the adjacent ketone carbonyl remains intact, giving the hydrolysis product the structural characteristics of a β-keto acid.

When Buß et al. used aromatic β-keto ethyl esters as model substrates to screen hydrolases, their reaction scheme illustrated the structural conversion of a β-keto ethyl ester into a β-keto acid through hydrolysis. The study also noted that the resulting β-keto acid is unstable and can undergo further decarboxylation.[6]

Figure 1. Model reaction showing hydrolase-mediated conversion of a β-keto ester into a β-keto acid. The figure uses an aromatic β-keto ethyl ester as the substrate. A hydrolase catalyzes ester-bond hydrolysis to form the corresponding β-keto acid. Although this model substrate is not an LY3509754 intermediate, the structural transformation illustrated—hydrolysis of a β-keto ester to form a β-keto acid—is the same as that occurring in the enzymatic hydrolysis step used to prepare the key LY3509754 α-bromoketone intermediate. The original study also noted that the resulting β-keto acid can subsequently undergo decarboxylation.[6]

Image source: Buß O, Jager S, Dold S-M, et al. Statistical Evaluation of HTS Assays for Enzymatic Hydrolysis of β-Keto Esters. PLOS ONE, 2016, 11(1): e0146104, Figure 1A. © 2016 Buß et al. Used under the Creative Commons Attribution 4.0 (CC BY 4.0) license.

3.3 Decarboxylation of the β-keto acid and formation of the α-bromoketone

β-Keto acids undergo decarboxylation more readily than ordinary aliphatic carboxylic acids. The classical mechanism is commonly described as proceeding through a six-membered cyclic transition state involving proton transfer and C–C bond cleavage, with the carboxyl carbon leaving as carbon dioxide and an enol being formed. The enol subsequently undergoes keto–enol tautomerization to generate the corresponding ketone.[3,5]

The key LY3509754 intermediate follows this same structural relationship. After Lipozyme TL IM hydrolyzes the ester group of the α-bromo β-keto ethyl ester to form the corresponding α-bromo β-keto acid, decarboxylation occurs and removes the carboxyl carbon from the molecular skeleton. The resulting enol subsequently tautomerizes to the ketone, while the original brominated methine carbon becomes a bromomethyl carbon, thereby forming the target α-bromoketone.[1]

This process simultaneously accomplishes two structural changes: removal of the temporary carboxyl carbon used to establish the 1,3-dicarbonyl system while retaining the previously introduced C–Br bond. The carboxylate ester unit is first used to establish the reactive environment of the β-keto ester. Hydrolysis then generates the β-keto acid, whose carboxyl carbon is subsequently removed from the final carbon skeleton through decarboxylation.

4. From TFA-Mediated Acidolysis to Lipase-Mediated Hydrolysis

4.1 The early route employed a carbon-skeleton design based on “bromination followed by decarboxylation”

A LY3509754-related patent published in 2020 used a β-keto ester route to prepare this α-bromoketone.[2]

The early route employed a tert-butyl β-keto ester. In the patent example, 19.5 g of substrate was treated with NBS and 2,6-dimethylpyridine in methanol at room temperature for 2.5 h and then held at −20 °C for 24 h. The resulting crude brominated intermediate was transferred into toluene, TFA was added, and the mixture was treated at 80 °C for 2 h. After silica-gel column purification, 10.3 g of the α-bromoketone was obtained in a reported yield of 56%.[2]

The tert-butyl ester is readily deprotected under acidic conditions to form the corresponding β-keto acid, which subsequently decarboxylates to generate the α-bromoketone. This intermediate β-keto acid was likewise not isolated separately in the patent example.

4.2 The scalable route changes the method used to generate the β-keto acid

The 2025 scalable route retains the same fundamental chemical relationship in which the β-keto ester controls α-carbon reactivity and the β-keto acid serves as a decarboxylatable structural unit.

What changes is the specific implementation:

The yields of the two routes cannot be compared directly on a one-to-one basis. The 56% yield in the early route encompasses bromination of the tert-butyl β-keto ester, TFA treatment, workup, and column chromatography, whereas the 85.9% yield corresponds only to the separate enzymatic hydrolysis–decarboxylation step performed after the α-bromo β-keto ethyl ester had already been obtained.

5. Function of the Temporary Carbon in the Synthetic Route

This segment of the LY3509754 synthesis illustrates a route design based on “temporary structural modulation of reactivity–functionalization–controlled removal.” In the 2025 route, the β-keto ester is constructed using a magnesium monoethyl malonate complex. Its central carbon is brominated and ultimately retained as the bromomethyl carbon, whereas the ester carbonyl carbon is removed as carbon dioxide through decarboxylation after hydrolysis generates the β-keto acid.[1]

This sequence of carbon-skeleton transformations provides three consecutive functions:

The scalable process does not change this carbon-skeleton design but instead changes the method used to generate the β-keto acid. The early route uses TFA to cleave the tert-butyl ester, followed by decarboxylation, whereas the 2025 route uses Lipozyme TL IM to hydrolyze the ethyl ester, accompanied by concomitant decarboxylation. The optimized process ultimately produced 110 kg of the α-bromoketone intermediate in an overall yield of 46.5%.[1,2]

6. Representative Chemicals Related to the Construction of the Key LY3509754 α-Bromoketone Intermediate: Key Building Blocks, Reaction Reagents, Mechanistic Models, and Process Solvents

Table 1. Core Route-Related Materials and Reaction-Control Reagents

Table 2. β-Dicarbonyl and Temporary Carboxylate Ester Mechanistic Models

Table 3. Route-Related Reaction, Analytical, and Workup Process Solvents

Note: The products listed above are representative Aladdin products related to scientific research. Specific applications should be determined according to product specifications, batch COAs, and the intended reaction or evaluation system. Additional product specifications, grades, and COA information can be searched on the Aladdin website using the product name/CAS number/catalog number.

References

[1] Yang Q, Lu Y, Beauchamp TJ, Frank SA, Ortiz-Medina X, Chen J, Liang L, Zhang X, Huang P. Development of a Scalable Process for an IL-17A Inhibitor LY3509754. Part II: Synthesis of the α-Bromoketone Intermediate Leveraging Concomitant Decarboxylation Following Enzymatic Ester Hydrolysis. Organic Process Research & Development, 2025, 29(4): 1006–1018. DOI: 10.1021/acs.oprd.5c00004.

[2] Coates DA, Frimpong K, Holloway WG, et al. Imidazo[1,2-b]pyridazine IL-17A Inhibitors. WO2020146194A1, 2020.

[3] McMurry J. Organic Chemistry. OpenStax, 2023. Section 22.7: Alkylation of Enolate Ions.

[4] Fernandez-Lafuente R. Lipase from Thermomyces lanuginosus: Uses and Prospects as an Industrial Biocatalyst. Journal of Molecular Catalysis B: Enzymatic, 2010, 62(3–4): 197–212. DOI: 10.1016/j.molcatb.2009.11.010.

[5] Ignatchenko AV, Springer ME, Walker JD, Brennessel WW. Alkyl Substituted Beta-Keto Acids: Molecular Structure and Decarboxylation Kinetics in Aqueous Solution and on the Surface of Metal Oxides. The Journal of Physical Chemistry C, 2021, 125(6): 3368–3384. DOI: 10.1021/acs.jpcc.0c10797.

[6] Buß O, Jager S, Dold S-M, Zimmermann S, Hamacher K, Schmitz K, Rudat J. Statistical Evaluation of HTS Assays for Enzymatic Hydrolysis of β-Keto Esters. PLOS ONE, 2016, 11(1): e0146104. DOI: 10.1371/journal.pone.0146104. CC BY 4.0.

More related articles are listed below:

Experimental Selection Logic for C-C Bond Construction: Understanding Fragment Coupling, Carbonyl Chain Extension, Olefination, and Late-Stage Bond-Forming Pathways by Bond-Forming Task

Understanding Cbz (Benzyloxycarbonyl): Selection Logic and Practical Value of a Classical Amino Protecting Group

From “Reduction First, Then Acylation” to “Direct Amidation”: An Unconventional Route to Amide Bond Formation from Nitro and Nitroso Substrates with α-Keto Carboxylic Acids

From Parent Piperidone to Derivatives: Structural Benchmarks, Classification Framework, and Application-Oriented Selection Guide

Pyridinones as “Property Knobs” in Drug Design: From Tautomers and H-Bonding Fingerprints to Product Selection (Tables A–C)

Triphenylphosphine Dibromide (PPh₃Br₂) Is More Than Just a Brominating Reagent: Experimental Selection Logic from Alcohol-to-Alkyl Bromide Conversion to Carboxylic Acid Activation and One-Pot Esterification, Vinyl Bromide Formation, and Nitrile Construction